Literature DB >> 16327986

Increased cell compaction can augment the resistance of HT-29 human colon adenocarcinoma spheroids to ionizing radiation.

Antonella Ferrante1, Gabriella Rainaldi, Paola Indovina, Pietro Luigi Indovina, Maria Teresa Santini.   

Abstract

One of the most important questions in tumor biology is the understanding of the mechanisms responsible for the resistance of cancer cells to radiotherapy. In the present study, the possible role played by cell-cell interactions in determining the response of tumor cells to ionizing radiation was investigated. HT-29 colon adenocarcinoma spheroids were irradiated with a dose of 15 Gy in two different stages of growth characterized by diverse degrees of compaction: loosely organized spheroids (early spheroids) and compacted spheroids (late spheroids). Morphological analyses demonstrated that late spheroids were less damaged than early spheroids. Moreover, analyses of the cell cycle and cell death showed that ionizing radiation induced necrosis in early spheroids and apoptosis in late ones. From these results it can be concluded that late, compacted spheroids are more resistant to ionizing radiation than early, loose spheroids. In order to understand the mechanisms regulating this compaction-induced resistance of late spheroids, E-cadherin/beta-catenin complex expression and distribution were analyzed. In late spheroids, E-cadherin/beta-catenin complexes were shown to be tethered to the cytoskeleton, and since this organization has been demonstrated to strengthen cell-cell adhesion in other systems, it can be postulated that the same is true in HT-29 spheroids. In conclusion, it can be hypothesized that compaction of HT-29 spheroids is mediated by the reorganization of E-cadherin/beta-catenin complexes on the plasma membrane and that this compaction may be responsible for the increase in resistance of HT-29 spheroids to ionizing radiation.

Entities:  

Mesh:

Year:  2006        PMID: 16327986

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Cell Tissue Res       Date:  2011-08-11       Impact factor: 5.249

2.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Enzyme-Induced Matrix Softening Regulates Hepatocarcinoma Cancer Cell Phenotypes.

Authors:  Youyun Liang; Nicholas Edwin Clay; Kathryn M Sullivan; Jiayu Leong; Altug Ozcelikkale; Max H Rich; Min Kyung Lee; Mei-Hsiu Lai; Hojeong Jeon; Bumsoo Han; Yen Wah Tong; Hyunjoon Kong
Journal:  Macromol Biosci       Date:  2017-07-06       Impact factor: 4.979

4.  Phenotypic profiling of Raf inhibitors and mitochondrial toxicity in 3D tissue using biodynamic imaging.

Authors:  Ran An; Dan Merrill; Larisa Avramova; Jennifer Sturgis; Maria Tsiper; J Paul Robinson; John Turek; David D Nolte
Journal:  J Biomol Screen       Date:  2013-12-20

5.  Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.

Authors:  Tadanori Mammoto; Amanda Jiang; Elisabeth Jiang; Dipak Panigrahy; Mark W Kieran; Akiko Mammoto
Journal:  Am J Pathol       Date:  2013-08-05       Impact factor: 4.307

6.  The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.

Authors:  Kenny Chitcholtan; Peter H Sykes; John J Evans
Journal:  J Transl Med       Date:  2012-03-06       Impact factor: 5.531

Review 7.  Spherical cancer models in tumor biology.

Authors:  Louis-Bastien Weiswald; Dominique Bellet; Virginie Dangles-Marie
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

Review 8.  Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research.

Authors:  Bárbara Pinto; Ana C Henriques; Patrícia M A Silva; Hassan Bousbaa
Journal:  Pharmaceutics       Date:  2020-12-06       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.